Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...
Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...
The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...
Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...
Lentils are full of fiber, which “slows down digestion,” once again reproducing the effect of the GLP-1 drugs, at a cost of ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...
Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...
A new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...
Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...
Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...